Navigation Links
Nexcelom Bioscience to Distribute FCS Express 4 Cytometry Software with Cellometer Vision CBA Instruments
Date:10/11/2011

LOS ANGELES, Oct. 11, 2011 /PRNewswire/ -- De Novo Software™, a leading provider of flow and image cytometry data analysis solutions, and Nexcelom Bioscience, a leading supplier of cell counting and analysis products for bioresearch and drug discovery, announced today a licensing agreement enabling Nexcelom to distribute De Novo Software's flagship product, FCS Express 4 Software.  

Under the terms of the agreement, Nexcelom will distribute the FCS Express 4 Cytometry Software to customers in the research, biotech and pharmaceutical markets worldwide.  The FCS Express 4 Software can natively import Nexcelom Cellometer® Vision data for visualization of multi-parametric results.  

With the Cellometer Vision CBA Analysis System, a drop-down menu of assays with pre-set optical module selection, exposure time, and data calculation/presentation set-up make imaging and analysis simple and repeatable. With just 20 Microlitres of sample and a few clicks, users obtain fluorescent cell images, dot plots, and histograms in pre-optimized layouts for specific cell-based assays. Researchers can view cell morphology real-time and archive cell images along with comprehensive analysis reports.

According to Jean Qiu, CTO at Nexcelom, "FCS Express 4 is helping us to improve the overall end-user experience, enabling scientists to focus less on the plotting and formatting process and more on results. We are excited to offer a simple, microscopy-based platform for cell-based assays as an alternative to more complex fluidic instruments."

De Novo Software launched FCS Express 4 in January of 2011.  In addition to fully customized analysis and reporting, the new software adds the ability to analyze image based data.  These novel tools significantly improve assay development, workflow, and enable rapid report generation with image based assays.

David Novo, De Novo Software's president said: "This is an exciting collaboration and business relationship.  We look forward to providing options for flexible data analysis and reporting platform for the Nexcelom Cellometer® Vision customers."

Peter Li, CEO at Nexcelom said: "Seamless integration of FCS Express 4 provides state-of-the-art data reporting and applications support for the Cellometer cell based assays.  De Novo Software is a key strategic partner in our continued effort to provide total solutions to simplify current work flows for our customers."

Michael Sjaastad, Director of Business Development at De Novo Software commented, "There is an unmet need for a common analysis platform for all cytometry data.  We look forward to building upon this key relationship to provide a general platform for data analysis and report generation used by scientists worldwide."

For more information, visit www.denovosoftware.com or www.nexcelom.com


'/>"/>
SOURCE De Novo Software
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Amarillo Biosciences Teams with Animal Shelters to Improve Health and Enhance Immunity of Cats and Dogs
2. Redwood Bioscience Appoints Peter Van Vlasselaer, PhD as Executive Chairman
3. Genesis Biosciences Announces New Hire and Promotions on Operational and Scientific Staff
4. Roka Bioscience Initiates External Trial for AOAC Certification
5. Sangamo BioSciences Announces Presentation at the 2011 UBS Global Life Sciences Conference
6. OBNs 2011 Annual Awards Dinner Celebrates UK Bioscience Success Stories
7. HUYA Bioscience International Forms Alliance With Zhejiang Chinese Medical University Life Science College
8. Ardea Biosciences Announces Positive End-of-Phase 2 Meetings with FDA for Lesinurad
9. Avantra Biosciences Changes Company Name to Courtagen Life Sciences, Inc.
10. BD Biosciences Announces Winners of Research Grant Program
11. 3-V Biosciences Appoints George W. Kemble, PhD, as Chief Scientific Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ASAE is introducing a hybrid membership model ... the option of joining or renewing through an organizational ... staff size, every employee in any size association or ... all available member benefits.   John H. ... options will allow organizations of any size and their ...
(Date:2/10/2016)... New York (PRWEB) , ... ... ... Inc. (NASDAQ: REGN) today announced that it has joined the Human Vaccines ... immunotherapies for infectious diseases and cancer. , The Human Vaccines Project ...
(Date:2/10/2016)... Wash., Feb. 10, 2016  IsoRay, Inc. (NYSE MKT: ... brachytherapy and medical radioisotope applications for the treatment of ... today announced its financial results for the second quarter ... 31, 2015. --> ... quarter of fiscal 2016, which ended December 31, 2015, ...
(Date:2/10/2016)... plc (NYSE: AGN ) a leading global pharmaceutical ... CEO and President, will be featured as the keynote ... Capital Markets Healthcare Conference on Tuesday, February 23, 2016 ... Hotel in New York, NY . ... accessed on Allergan,s Investor Relations web site at ...
Breaking Biology Technology:
(Date:2/5/2016)... 5, 2016 http://www.researchandmarkets.com/research/5kvw8m/global_facial ... "Global Facial Recognition Market 2016-2020" ... http://www.researchandmarkets.com/research/5kvw8m/global_facial ) has announced the addition of ... report to their offering. --> ... has announced the addition of the ...
(Date:2/3/2016)... 2016 --> ... "Automated Fingerprint Identification System Market by Component (Hardware and ... & Finance, Government, Healthcare, and Transportation) and Geography - ... is expected to be worth USD 8.49 Billion by ... and 2020. The transformation and technology evolution from the ...
(Date:2/2/2016)... , Feb. 2, 2016  BioMEMS devices ... primarily focused on medical screening and diagnostic ... parameters. Wearable devices that facilitate and assure ... of movement are being bolstered through new ... biomedical signal acquisition coupled with wireless connectivity ...
Breaking Biology News(10 mins):